Cognition Therapeutics (CGTX) PT Lowered to $7 at Brookline Capital Markets
Tweet Send to a Friend
Brookline Capital Markets analyst Tyler Bussian raised the price target on Cognition Therapeutics (NASDAQ: CGTX) to $7.00 while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
